US Patent 7118854 PAK2: modulators of lymphocyte activation
Patent 7118854 was granted and assigned to Rigel Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7118854 PAK2: modulators of lymphocyte activation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.